Page last updated: 2024-08-17

lysine and olmesartan medoxomil

lysine has been researched along with olmesartan medoxomil in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inagi, R; Ishikawa, N; Koike, H; Kurokawa, K; Miyata, T; Mizuno, M; Nangaku, M; Sada, T; Ueda, Y; van Ypersele de Strihou, C; Yuzawa, H	1
Akizawa, T; Aoshima, Y; Hirai, Y; Honda, H; Hosaka, N; Michihata, T	1

Trials

1 trial(s) available for lysine and olmesartan medoxomil

Article	Year
Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients. Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome	2012

Article

Year

Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2012, Volume: 34, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Arginine; Benzimidazoles; Benzoates; Blood Pressure; Female; Glycation End Products, Advanced; Humans; Hypertension, Renal; Imidazoles; Inflammation; Kidney Failure, Chronic; Lysine; Male; Olmesartan Medoxomil; Oxidative Stress; Pilot Projects; Prospective Studies; Renal Dialysis; Telmisartan; Tetrazoles; Treatment Outcome

2012

Other Studies

1 other study(ies) available for lysine and olmesartan medoxomil

Article	Year
Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5 Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles	2003

Article

Year

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.

Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5

Topics: Animals; Antihypertensive Agents; Arginine; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glycation End Products, Advanced; Hydralazine; Hypertension, Renal; Imidazoles; Immunohistochemistry; In Vitro Techniques; Kidney; Lipids; Lysine; Male; Olmesartan Medoxomil; Oxidation-Reduction; Proteinuria; Rats; Tetrazoles

2003